We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+3.29%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$43.8B
AUM Growth
+$2.95B
Cap. Flow
+$2.92B
Cap. Flow %
6.68%
Top 10 Hldgs %
29.71%
Holding
2,321
New
255
Increased
1,689
Reduced
325
Closed
50

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$408M
2
NVDA icon
NVIDIA
NVDA
+$395M
3
MSFT icon
Microsoft
MSFT
+$382M
4
AMZN icon
Amazon
AMZN
+$253M
5
PLTR icon
Palantir
PLTR
+$148M

Sector Composition

Rank Sector Weight
1 Technology 32.42%
2 Consumer Discretionary 10.78%
3 Consumer Staples 10.15%
4 Industrials 10.05%
5 Financials 9.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CDZI icon
2151
Cadiz
CDZI
$266M
$61.7K ﹤0.01%
+11,863
New +$42.8K
GETY icon
2152
Getty Images
GETY
$184M
$61K ﹤0.01%
28,255
+9,297
+49% +$30.3K
DBI icon
2153
Designer Brands
DBI
$277M
$61K ﹤0.01%
+11,419
New +$63.9K
SB icon
2154
Safe Bulkers
SB
$781M
$60.7K ﹤0.01%
17,008
+5,596
+49% +$23.4K
CIO
2155
DELISTED
City Office REIT
CIO
$60.6K ﹤0.01%
+10,978
New +$60.3K
KLTR icon
2156
Kaltura
KLTR
$211M
$60.4K ﹤0.01%
27,454
+9,291
+51% +$17K
PHLT
2157
DELISTED
Performant Healthcare Inc
PHLT
$60.2K ﹤0.01%
19,919
+6,555
+49% +$22.5K
ONL
2158
Orion Office REIT
ONL
$148M
$58.7K ﹤0.01%
15,813
+5,204
+49% +$20.5K
IHRT icon
2159
iHeartMedia
IHRT
$535M
$58.6K ﹤0.01%
29,588
+10,061
+52% +$21.3K
PGEN icon
2160
Precigen
PGEN
$1.93B
$58K ﹤0.01%
51,822
+10,900
+27% +$9.3K
LRMR icon
2161
Larimar Therapeutics
LRMR
$416M
$57.5K ﹤0.01%
+14,870
New +$98.2K
TNGX icon
2162
Tango Therapeutics
TNGX
$4.34B
$57.2K ﹤0.01%
18,524
+3,178
+21% +$14.8K
REI icon
2163
Ring Energy
REI
$322M
$56.8K ﹤0.01%
41,736
+13,733
+49% +$20.6K
VSTM icon
2164
Verastem
VSTM
$532M
$56.5K ﹤0.01%
+10,925
New +$43K
BHR
2165
Braemar Hotels & Resorts
BHR
$153M
$55.7K ﹤0.01%
18,563
+6,109
+49% +$19.8K
FATE icon
2166
Fate Therapeutics
FATE
$281M
$55.5K ﹤0.01%
33,645
+14,728
+78% +$37.1K
ARAY icon
2167
Accuray
ARAY
$28.4M
$54.1K ﹤0.01%
27,308
+9,187
+51% +$17.4K
MRSN
2168
DELISTED
Mersana Therapeutics
MRSN
$54.1K ﹤0.01%
1,512
+655
+76% +$33.9K
TLS icon
2169
Telos
TLS
$337M
$53.1K ﹤0.01%
15,512
+5,105
+49% +$18.3K
PROK icon
2170
ProKidney
PROK
$308M
$52.2K ﹤0.01%
30,879
+11,250
+57% +$20.3K
ALEC icon
2171
Alector
ALEC
$164M
$51.7K ﹤0.01%
27,367
+6,367
+30% +$24K
JRVR icon
2172
James River Group Holdings
JRVR
$218M
$51.4K ﹤0.01%
+10,559
New +$58.2K
LFMD icon
2173
LifeMD
LFMD
$179M
$50.9K ﹤0.01%
+10,290
New +$53.9K
HRTX icon
2174
Heron Therapeutics
HRTX
$86.3M
$50.6K ﹤0.01%
33,063
+10,880
+49% +$17.6K
FSP
2175
Franklin Street Properties
FSP
$44.8M
$50.3K ﹤0.01%
27,470
+9,040
+49% +$16.5K

Similar funds

ProShare Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, ProShare Advisors held 2,321 positions worth $43.8B, up 7.2% from $40.8B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

ProShare Advisors deployed $2.92B of net new capital in Q4 2024, opening 255 new positions and adding to 1,689 existing holdings. Its largest new stake was Applovin: 338,942 shares worth $110M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 29% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Walmart Inc, an estimated $285M trimmed.

  • ProShare Advisors's largest Q4 2024 buy was Applovin: 338,942 shares worth $110M.
  • ProShare Advisors added most to Apple in Q4 2024, an estimated $408M increase.
  • ProShare Advisors's biggest Q4 2024 reduction was Walmart Inc, cutting an estimated $285M.
  • ProShare Advisors fully exited PetIQ, Inc. Class A Common Stock in Q4 2024, selling an estimated $3.25M.
  • ProShare Advisors's ten largest holdings make up 30% of its $43.8B portfolio in Q4 2024.
  • ProShare Advisors opened 255 new positions and closed 50 in Q4 2024.
  • ProShare Advisors's portfolio value rose 7.2% quarter-over-quarter to $43.8B.

Based on ProShare Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.